All Posts

U.S., EPO and Chinese Software-Related Patent Grants Remained Steady in 2023

As an update to my previous posts from 2017, 2019, 2020, March 2021, August 2021, 2022, and 2023, it has now been almost a decade since the U.S. Supreme Court’s 2014 Alice Corp. v. CLS Bank decision. Yet the debate still rages over when a software (or computer-implemented) claim is patentable versus being simply an abstract idea “free to all men and reserved exclusively to none” (as eloquently phrased 76 years ago by then-Supreme Court Justice Douglas in Funk Bros. Seed Co. v. Kalo Inoculant Co.).

Brazilian Lawmaker Introduces Bill to Allow AI as Inventor

On February 20, 2024, a Brazilian congress member, Antônio Luiz Rodrigues Mano Júnior (known as Júnior Mano), introduced a bill to amend the national IP Statute (Law #9,279/96) and regulate the ownership of inventions generated by artificial intelligence systems. Bill #303/2024 proposes the addition of a paragraph to Article 6 of the IP Statute, which regulates ownership of inventions, with the following wording: “in the case of inventions autonomously generated by artificial intelligence system, the patent can be requested in the name of the artificial intelligence system that has created the invention, being the artificial intelligence system considered the inventor and owner of rights arising from the invention.”

USPTO Issues Updated Obviousness Guidance Tracing 15 Years of Case Law Following KSR

On February 27, the U.S. Patent and Trademark Office (USPTO) published a notice in the Federal Register providing updated guidance for agency decision-makers on making proper determinations of obviousness under the U.S. Supreme Court’s 2007 ruling in KSR International Co. V. Teleflex Inc. While the USPTO’s examiner guidance doesn’t constitute substantive rulemaking, it traces 15 years of case law from the U.S. Court of Appeals for the Federal Circuit to clarify several areas of confusion stemming from the Supreme Court’s calls for a flexible approach to the obviousness analysis for patent validity.

Happy 40th Anniversary, Judge Pauline Newman!

Today, Judge Pauline Newman celebrates 40 years on the U.S. Court of Appeals for the Federal Circuit (CAFC). Newman was appointed to the court on January 30, 1984, by then-President Ronald Reagan and officially assumed office on February 28, 1984. Newman was the first judge to be appointed directly to the Federal Circuit; all of the standing judges at that time attained their position through the merger of the Court of Customs and Patent Appeals and the appellate division of the United States Court of Federal Claims. She filled the Federal Circuit vacancy created at that time by Judge Philip Nichols Jr., who had taken senior status.

IP Goes Pop!—Techno-Humanism: The IP of Integrating People and Technology

Welcome to the synthesized world of “Techno-Humanism,” the latest episode from IP Goes Pop!®, where the promises and legal challenges of an augmented future are decoded through the lens of pop culture. Join Co-hosts, Shareholders and Intellectual Property attorneys Michael Snyder and Joseph Gushue as they navigate the interface of IP and transformative technologies that can augment human capabilities, both in science fiction and emerging reality.

Secrecy and Taylor Swift: What Conspiracy Theories Reveal About Our Growing Distrust of Institutions

Maintaining control over trade secrets is mostly about risk management, and one dimension of risk lies in having to tell hundreds or thousands of employees to keep quiet and then depend on each of them to do so. Human nature being what it is, risk increases quite a bit when the secret is about something really big and important. And it increases even more if the secret shows that your employer is lying to the public. Indeed, you might think that kind of information is the very hardest to keep under wraps. But there seems to be a growing number of people who think it’s quite easy.

Top-Down and Bottom-Up Approaches in Writing a Patent Application

Writing a useful and enforceable patent application is not an easy task. A number of articles show how to draft a patent application. For example, Gene Quinn of IPWatchdog published a series of articles with tips to avoid mistakes or pitfalls. Automated software and AI-assisted drafting tools have also become available, but there have been ethical and practical concerns about relying on AI. Instead of discussing the specific details of the steps in writing a patent application or the pros and cons of automated or AI tools, I will focus on the overall strategies or approaches.

A Perspective on USPTO Rulemaking Following In re Chestek

There are many views on the significance of In re Chestek, No. 2022-1843 (February 14, 2024) to the U.S. Patent and Trademark Office (USPTO) rulemaking process. One question I have asked myself is what I would do differently after Chestek if I were still involved in rulemaking at the USPTO. The simple answer is almost nothing: I would cite Chestek instead of the other decisions in the Administrative Procedure Act (APA) section of a proposed or final rule.

CAFC Affirms Albright Rulings in Alexa Shopping List Patent Suit

On February 26, the U.S. Court of Appeals for the Federal Circuit issued a precedential decision in Freshub, Ltd. v. Amazon.com, Inc., affirming a ruling by U.S. District Judge Alan Albright of the Western District of Texas in the face of appeals from both parties to the case. The Federal Circuit left the lower ruling intact after finding that the record developed at trial did not establish clear error with regards either to Freshub’s patent infringement allegations or Amazon’s inequitable conduct defense.

Three Congressional Letters Show the March-In Debate Has Shifted

When the Biden Administration unleashed its proposed march-in guidelines last December, it claimed they would be a powerful tool for lowering drug prices by allowing the government to “march in” to license copiers under the authorities of the Bayh-Dole Act. It did so despite previously joining every other Administration denying price control petitions as not authorized under the law. It should have known the proposal would have minimal impact on drug prices—but would have a devastating impact on American innovation. That’s because the guidelines apply to all federal R&D agencies—not just the National Institutes of Health — so they cover inventions across the spectrum, not just the life sciences.  Now the chickens are coming home to roost. Three Congressional letters illustrate the point.

Patently Strategic Podcast: James Howard and the Black Inventors Hall of Fame

What would you have been without a role model? What would you have done had you not known your career path was even an option? The answers to these career and life-defining questions often come down to exposure, access, and whether or not we could picture ourselves doing something in the first place. I doubt there are many readers on here who are not regularly awe-inspired by the incredible work of the inventors we’re fortunate to know and serve. There are few nobler or more important professions. While we already know this and possibly take that knowledge for granted, our future depends on as many kids as possible – from as many backgrounds as possible – being inspired by, and personally identifying with, this world-shaping path. Our special guest in this month’s episode, James Howard, is taking on that challenge.

What Can You Do if You Buy Stolen or Forged Art and Antiquities?

In February 2023, an art dealer in Palm Beach, Florida admitted to selling millions of dollars’ worth of counterfeit artwork to unwitting buyers. Daniel Elie Bouaziz of Danieli Fine Art and Galerie Danieli in Palm Beach County purchased cheap reproductions online, forged provenance and authenticity paperwork, and resold the forged artworks for a hefty profit. Two months later, in April 2023, a Los Angeles-based auctioneer confessed to creating forged Basquiat pieces for display in the Orlando Museum of Art. Michael Barzman and an unidentified co-conspirator in the case created 20 to 30 of these fake paintings.

Examining the Possibility of Compulsory Copyright Licensing for LLM Training

ChatGPT and similar generative artificial intelligence (AI) tools rely on large language models (LLMs). LLMs are fed massive amounts of content, such as text, music, photographs and film, which they analyze to discover statistical relationships among these inputs. This process, describe as “training” the LLMs, gives them the ability to generate similar content and to answer questions with seeming authority. The business community, and society at large, seems convinced that AI powered by LLMs holds great promise for increases in efficiency. But multiple lawsuits alleging copyright infringement could create a drag on development of LLMs, or worse, tip the competitive balance towards offshore enterprises that enjoy the benefits of legislation authorizing text and data mining. A lot seems to hang on the question of whether LLM training involves copyright infringement or instead is a fair use of copyrighted content.

Other Barks & Bites for Friday, February 23: Intel and Microsoft Announce Landmark Chip and IP Deal; Court Overturns $1 Billion Copyright Infringement Ruling Against Cox; and Reddit and Google Set to Announce AI Content Licensing Agreement

This week in Other Barks & Bites: Intel and Microsoft announce a custom chip deal worth up to $15 billion; the Justice Department announces its first Chief AI Officer; and an appeals court overturns a $1 billion ruling for copyright infringement against Cox Communications.

GIPC’s International IP Index Shows Stagnation in Legal Frameworks Among Global IP Leaders

On February 22, the U.S. Chamber of Commerce’s Global Innovation Policy Center (GIPC) released the 2024 International IP Index, which provides an annual snapshot of the impact of legal developments in intellectual property (IP) on the innovation ecosystem in dozens of nations across the world. While this 12th version of the GIPC’s index noted some positive developments in national IP frameworks, stagnation among the recurring leaders of the IP Index is a major concern given growing efforts by governments to control prices in critical sectors of the economy, especially in pharmaceuticals.